Thiazolidinedione addition reduces the serum retinol-binding protein 4 in type 2 diabetic patients treated with metformin and sulfonylurea. (Q46566219)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18514142%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Thiazolidinedione addition reduces the serum retinol-binding protein 4 in type 2 diabetic patients treated with metformin and sulfonylurea (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18514142%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18514142%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Kun-Der Lin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18514142%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Yu-Hung Chang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18514142%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Chiao-Ling Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18514142%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Pi-Jung Hsiao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18514142%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Tzu-Hui Li

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18514142%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Shyi-Jang Shin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18514142%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

16 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18514142%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

published in

Translational Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18514142%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

151

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18514142%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

309-314

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18514142%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18514142%20AND%20SRC:MED&resulttype=core&format=json

Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus.

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Adipose tissue as source and target for novel therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

RBP4, an unexpected adipokine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Thiazolidinediones improve insulin sensitivity in adipose tissue and reduce the hyperlipidaemia without affecting the hyperglycaemia in a transgenic model of type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Microalbuminuria is a major determinant of elevated plasma retinol-binding protein 4 in type 2 diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Retinol binding protein-4 levels and clinical features of type 2 diabetes patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Plasma Levels and Adipose Tissue Messenger Ribonucleic Acid Expression of Retinol-Binding Protein 4 Are Reduced during Calorie Restriction in Obese Subjects but Are Not Related to Diet-Induced Changes in Insulin Sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Insulin resistance and improvements in signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Pioglitazone: a review of its use in type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Improved insulin sensitivity and adipose tissue dysregulation after short-term treatment with pioglitazone in non-diabetic, insulin-resistant subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Retinol-binding protein 4, insulin resistance, and type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

The worldwide obesity epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Cutoff Values for Normal Anthropometric Variables in Asian Indian Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Influence of age on the association of retinol-binding protein 4 with metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Serum levels of adipokine retinol-binding protein-4 in relation to renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.04.003

10.1016/J.TRSL.2008.04.003

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18514142%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference